All doses of Eli Lilly & Co.’s blockbuster new drugs to treat diabetes and weight loss are available in the US after more than a year and a half of shortages. The Food and Drug Administration ...

GLP-1 medications offer promising benefits for obesity and diabetes patients, with studies showing reduced heart attack risk ...

Drug giant Eli Lilly says its weight-loss drug tirzepatide ... and lifestyle changes available. In the SURMOUNT-1 trial, Lilly gave nearly 2,000 volunteers with pre-diabetes and obesity or ...

Pennsylvania Governor Josh Shapiro's office has said it is looking to change eligibility for weight loss drugs as part of its ...

U.S. drugmaker Eli Lilly said on Monday it will offer the higher-dose versions of its popular weight-loss drug Zepbound on ...

Tufts University scientists are aiming to revolutionize the future of weight loss drugs by engineering a new compound that ...

Eli Lilly's drug, called eloralintide, helped some patients lose more than 11% of their body weight in three months.

The weight-loss drugs that have become so popular in recent years actually began as diabetes medications ... approved to treat prediabetes right now,” says Dr. Michael Weintraub, clinical ...

Many folks in NC can’t access Ozempic due to limited insurance coverage. But policy changes and falling prices may expand access soon.

Weight-loss drugs like Ozempic and Wegovy are used by more than 15 million adults in the U.S., or 4.5% of the population.

America's famous drug manufacturer Eli Lilly has launched the weight loss ... Now its availability in India is expected to provide great relief to patients suffering from obesity and type-2 diabetes.

Last week, Australia ’s Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnoea, ...